Dyne Therapeutics (DYN)
(Delayed Data from NSDQ)
$24.73 USD
+1.04 (4.37%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $24.69 -0.04 (-0.16%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -0.80 |
EPS Last Quarter | -1.09 |
Last EPS Surprise | -18.48% |
ABR | 1.00 |
Earnings ESP
|
0.18% |
---|---|
Current Year | -3.25 |
Next Year | -3.14 |
EPS (TTM) | -3.94 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 105.07M |
# of Estimates | NA | NA | NA | 1 |
High Estimate | NA | NA | NA | 105.07M |
Low Estimate | NA | NA | NA | 105.07M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.80 | -0.79 | -3.25 | -3.14 |
# of Estimates | 7 | 7 | 7 | 6 |
Most Recent Consensus | -0.83 | -0.83 | -3.33 | -2.19 |
High Estimate | -0.76 | -0.67 | -2.82 | -2.19 |
Low Estimate | -0.83 | -0.87 | -3.60 | -4.48 |
Year ago EPS | -0.78 | -1.08 | -3.95 | -3.25 |
Year over Year Growth Est. | -2.56% | 26.85% | 17.72% | 3.58% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 3 | 3 | 3 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.80 | -0.79 | -3.25 | -3.14 |
7 Days Ago | -0.80 | -0.79 | -3.25 | -3.14 |
30 Days Ago | -0.80 | -0.79 | -3.23 | -3.01 |
60 Days Ago | -0.74 | -0.74 | -3.20 | -2.65 |
90 Days Ago | -0.70 | -0.71 | -3.00 | -2.51 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.80 | -0.83 | -3.40 | -3.77 |
Zacks Consensus Estimate | -0.80 | -0.79 | -3.25 | -3.14 |
Earnings ESP | 0.18% | -4.68% | -4.52% | -20.19% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.09 | -0.99 | -1.08 | -0.78 | NA |
Estimate | -0.92 | -0.86 | -0.81 | -0.77 | NA |
Difference | -0.17 | -0.13 | -0.27 | -0.01 | -0.15 |
Surprise | -18.48% | -15.12% | -33.33% | -1.30% | -17.06% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more